Stopping inflammatory immune cells that block healing after spinal cord injury

Exploring the therapeutic mechanisms of proinflammatory myelin-laden macrophages retention in the injured spinal lesion core

NIH-funded research Florida State University · NIH-11263659

Looking at why certain inflammation-causing immune cells that eat myelin get stuck in spinal cord scars and finding ways to help nerves regrow for people with spinal cord injuries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida State University NIH-funded
Lab location1 site (Tallahassee, United States)
Project IDNIH-11263659 on NIH RePORTER

What this research studies

You will hear about work that follows immune cells called macrophages that swallow myelin after a spinal cord injury and then become sticky and stay in the injury core. The team is studying how these myelin-laden macrophages interact with blood vessel cells and deposited scaffolding proteins (the extracellular matrix) that make them cling to the injury site. They will use lab experiments that track cell movement, measure adhesion molecules, and test approaches that might reduce this stickiness so macrophages can clear debris and support repair. The goal is to identify targets that could later be used to develop treatments that let nerves grow back into the injured area.

Who could benefit from this research

Good fit: People living with spinal cord injuries (acute or chronic) who are interested in future therapies addressing inflammation and scar-related barriers to healing.

Not a fit: People without spinal cord injury or those whose disability is unrelated to post-injury inflammation or myelin debris are unlikely to benefit directly from this work.

Why it matters

Potential benefit: If successful, this work could lead to therapies that reduce harmful inflammation in the injury core and promote nerve regrowth after spinal cord injury.

How similar studies have performed: Prior preclinical studies show macrophage behavior affects spinal repair, but targeting the specific adhesion of myelin-laden macrophages to the injury core is a relatively new approach.

Where this research is happening

Tallahassee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.